Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Except the point that it will take years to get through human trials.
IMO the first rounds, given the relatively fast treatment cycle, would not take years to see results.
Best of luck to them.
Please explain:
- How does this impact PPS?
- Will this induce sell pressure?
- What does the L2 imply?
- Will we or won't be make it above the arbitrary nickel line?
- What will this due to investor confidence?
- Is the long term outlook for RDGL now dimmed?
TIA
Thank you for your actual expertise on the subject matter.
MK still delivering--albeit at a slower pace than we (the microwave generation) would prefer.
Two words: wrong person.
Sorry, we're asking for rtg to respond.
It's so ugly that JHU and Mayo are--still partners.
They won't.
It is. IDE submittal to come.
So sorry for your loss.
Actually, if they get FDA approval for human trials, negativity for that milestone would be senseless.
Sucks to be them.
I purchased some as well--to hedge against my own alarmism.
And?
As the saying goes (both ways), past performance is not indicative of the future.
All positive progress.
All great news.
If that were the spittin' truth, then why do:
Writer's write.
Poets poet.
And
Propagandizers propagandize
Slanderers slander
Regretters regret
Mourners mourn
They make not break bones, but words still matter.
The truth can hurt.
Truth teller!
Navel gazing
Tell me something new.
That's too bad.
Serious. Oh well.
Why does MK need to up his communication game?
Some people here have hemmed and hawed (and rightfully so) about how the only milestones that will matter and make positive price action will be IDE submission and acceptance--not mind-numbing tweets.
But now, somehow, for some people, his communication is impacting the forward development of this company? How so?
There's a saying that one should major in the majors. MK has done so.
Job 1: Lower the company debt — DONE
Job 2: Create a new plan and begin executing against it — DONE
Job 3: Get the patent situated — DONE
Job 4: Strengthen the investor base and raise funding as needed — DONE
Job 5: Be methodical, precise, and flexible given the circumstances — DONE
Or we can navel-gaze over the minors such as:
1. Communication style
2. PTO
3. Day to day price action
Here here.
Unfortunately, I could not agree more.
Maybe .02 by EOW.
Runway is over by Black Friday.
I did not.
Genius!
Wow. I could care less. Too busy reading LinkedIn posts right now.
From your opinion.
Maybe because its cancer! ;)
How does MK drop the ball when there's no material consequence to "timely" announcing the patent? Was there some actual deadline to meet?
If the patent wasn't going to substantially impact the PPS. then the the timing of when it's announced is essentially meaningless.
Right now, things are looking good for IDE.
Dude, you've stated before that the only big ticket movers here are the IDE submission and approval.
While the patent is a mission critical milestone, I doubt it was going to be an earth shattering influence on the stock price if it were PR'ed more prominently.
Nothing else matters at this stage.
Clearly--it was a staycation.
Your opinion ? all investors.
I'm substantially invested in this and don't view all their communications as meaningless or inane. Were some of them? Sure. All? No.
I honestly disagree.
Appreciate the play-by-play.
Honest question: Is the intention of these posts meant to tamp down the pumping?
Is what it is.